Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Volume

"Almost 300K shares so far. This is encouraging."

I guess I'm really missing something that is obvious (to you). 300K vs. 450 million shares outstanding at .10 per share???? I don't consider that much volume - in fact I think it's kind of sad - but expected none the less. The company must generate "huge" revenue or there will be no significant SP appreciation. No one is going to get fooled by this company again.

Share
New Message
Please login to post a reply